{{Rsnum
|rsid=3755486
|Chromosome=2
|position=174767158
|Orientation=plus
|GMAF=0.3421
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 18.6 | 51.3 | 30.1
| HCB | 54.7 | 38.0 | 7.3
| JPT | 54.0 | 39.8 | 6.2
| YRI | 89.8 | 10.2 | 0.0
| ASW | 75.4 | 19.3 | 5.3
| CHB | 54.7 | 38.0 | 7.3
| CHD | 55.0 | 38.5 | 6.4
| GIH | 56.4 | 38.6 | 5.0
| LWK | 95.5 | 4.5 | 0.0
| MEX | 19.0 | 51.7 | 29.3
| MKK | 80.1 | 18.6 | 1.3
| TSI | 26.5 | 42.2 | 31.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=23232035
|Title=Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans
|OA=1
}}

{{PMID Auto
|PMID=17373692
|Title=No evidence for association between 19 cholinergic genes and bipolar disorder.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}